Celgene and IBM Watson to develop new offering for patient safety monitoring
Celgene and IBM Watson Health will co-develop a new offering that aims to enhance pharmacovigilance methods used to collect, assess, monitor, and report adverse drug reactions.
The…
Read More...
Read More...